Standout Papers

NF-κB-dependent induction of microRNA miR-146,... 1986 2026 1999 2012 3.6k
  1. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses (2006)
    Konstantin D. Taganov, Mark Boldin et al. Proceedings of the National Academy of Sciences
  2. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death (1996)
    Amer A. Beg, David Baltimore Science
  3. NF-κB: Ten Years After (1996)
    Patrick A. Baeuerle, David Baltimore Cell
  4. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins (1989)
    Cornelis Murre, Patrick Page-McCaw et al. Cell
  5. Multiple nuclear factors interact with the immunoglobulin enhancer sequences (1986)
    Ranjan Sen, David Baltimore Cell
  6. Production of high-titer helper-free retroviruses by transient transfection. (1993)
    Warren S. Pear, Garry P. Nolan et al. Proceedings of the National Academy of Sciences
  7. IκB: a Specific Inhibitor of the NF-κB Transcription Factor (1988)
    Patrick A. Baeuerle, David Baltimore Science
  8. An inducible transcription factor activates expression of human immunodeficiency virus in T cells (1987)
    Gary J. Nabel, David Baltimore Nature
  9. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism (1986)
    Ranjan Sen, David Baltimore Cell
  10. Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome (1990)
    George Q. Daley, Richard A. Van Etten et al. Science
  11. Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors (2002)
    Carlos Lois, Elizabeth J. Hong et al. Science
  12. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus (1983)
    Richard S. Mann, Richard C. Mulligan et al. Cell
  13. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence (1989)
    Cornelis Murre, Patrick Page-McCaw et al. Cell
  14. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB (1995)
    Amer A. Beg, William C. Sha et al. Nature
  15. MicroRNA-155 is induced during the macrophage inflammatory response (2007)
    Ryan M. O’Connell, Konstantin D. Taganov et al. Proceedings of the National Academy of Sciences
  16. NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control (1989)
    Michael J. Lenardo, David Baltimore Cell
  17. The IκB-NF-κB Signaling Module: Temporal Control and Selective Gene Activation (2002)
    Alexander Hoffmann, Andre Levchenko et al. Science
  18. 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology (2017)
    Qian Zhang, Michael J. Lenardo et al. Cell
  19. Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of RNA Tumour Viruses (1970)
    David Baltimore Nature
  20. The “initiator” as a transcription control element (1989)
    Stephen T. Smale, David Baltimore Cell
  21. Physiological and pathological roles for microRNAs in the immune system (2010)
    Ryan M. O’Connell, Dinesh S. Rao et al. Nature reviews. Immunology
  22. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. (1990)
    Towia A. Libermann, David Baltimore Molecular and Cellular Biology
  23. RAG-1 and RAG-2, Adjacent Genes That Synergistically Activate V(D)J Recombination (1990)
    Marjorie A. Oettinger, David G. Schatz et al. Science
  24. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes (1986)
    Harinder Singh, Ranjan Sen et al. Nature
  25. Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB" (1990)
    Sankar Ghosh, David Baltimore Nature
  26. Identification of a Ten-Amino Acid Proline-Rich SH3 Binding Site (1993)
    Ruibao Ren, Bruce J. Mayer et al. Science
  27. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses (1995)
    William C. Sha, Hsiou-Chi Liou et al. Cell
  28. The V(D)J recombination activating gene, RAG-1 (1989)
    David G. Schatz, Marjorie A. Oettinger et al. Cell
  29. MicroRNAs: new regulators of immune cell development and function (2008)
    David Baltimore, Mark Boldin et al. Nature Immunology
  30. Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses (2010)
    Li‐Fan Lu, Mark Boldin et al. Cell
  31. Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal (1990)
    Sankar Ghosh, Paul Tempst et al. Cell
  32. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo (1991)
    Andrew B. Lassar, Robert L. Davis et al. Cell
  33. Immunoglobulin gene transcription is activated by downstream sequence elements (1983)
    Cary Queen, David Baltimore Cell
  34. ATR disruption leads to chromosomal fragmentation and early embryonic lethality (2000)
    Eric J. Brown, David Baltimore Genes & Development
  35. Circuitry of nuclear factor κB signaling (2006)
    Alexander Hoffmann, David Baltimore Immunological Reviews
  36. Daxx, a Novel Fas-Binding Protein That Activates JNK and Apoptosis (1997)
    Xiaolu Yang, Roya Khosravi‐Far et al. Cell
  37. MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development (2010)
    Ryan M. O’Connell, Daniel Kahn et al. Immunity
  38. microRNA Regulation of Inflammatory Responses (2012)
    Ryan M. O’Connell, Dinesh S. Rao et al. Annual Review of Immunology
  39. The Selective Downregulation of Class I Major Histocompatibility Complex Proteins by HIV-1 Protects HIV-Infected Cells from NK Cells (1999)
    George B. Cohen, Rajesh T. Gandhi et al. Immunity
  40. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice (2011)
    Mark Boldin, Konstantin D. Taganov et al. The Journal of Experimental Medicine
  41. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. (1996)
    Yang Xu, Terry Ashley et al. Genes & Development
  42. Inositol phosphatase SHIP1 is a primary target of miR-155 (2009)
    Ryan M. O’Connell, Aadel A. Chaudhuri et al. Proceedings of the National Academy of Sciences
  43. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes (1986)
    Louis M. Staudt, Harinder Singh et al. Nature
  44. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. (1988)
    Winship Herr, Richard A. Sturm et al. Genes & Development
  45. The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene (1986)
    Yinon Ben‐Neriah, George Q. Daley et al. Science
  46. Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow (1998)
    Warren S. Pear, Juli P. Miller et al. Blood
  47. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B all (1990)
    Mark P. Kamps, Cornelis Murre et al. Cell
  48. Ordered rearrangement of immunoglobulin heavy chain variable region segments. (1984)
    Frederick W. Alt, George D. Yancopoulos et al. The EMBO Journal
  49. Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a γ2a variable region (1981)
    Alfred L.M. Bothwell, Michael Paskind et al. Cell
  50. Protein-Binding Sites in Ig Gene Enhancers Determine Transcriptional Activity and Inducibility (1987)
    Michael J. Lenardo, Jacqueline W. Pierce et al. Science
  51. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 (2002)
    F. Xiao‐Feng Qin, Dong Sung An et al. Proceedings of the National Academy of Sciences
  52. NF-κB functions in synaptic signaling and behavior (2003)
    Mollie K. Meffert, Brian J. Wiltgen et al. Nature Neuroscience
  53. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. (1996)
    Warren S. Pear, Jon C. Aster et al. The Journal of Experimental Medicine
  54. Defective Viral Particles and Viral Disease Processes (1970)
    Alice Huang, David Baltimore Nature
  55. Chimeric Nucleases Stimulate Gene Targeting in Human Cells (2003)
    Matthew H. Porteus, David Baltimore Science
  56. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder (2008)
    Ryan M. O’Connell, Dinesh S. Rao et al. The Journal of Experimental Medicine
  57. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides (1992)
    Gabriel Waksman, Dorothea Kominos et al. Nature
  58. Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines (1984)
    George D. Yancopoulos, Stephen Desiderio et al. Nature
  59. A detailed model of reverse transcription and tests of crucial aspects (1979)
    Eli Gilboa, Sudha W. Mitra et al. Cell
  60. MicroRNAs as regulatory elements in immune system logic (2016)
    Arnav Mehta, David Baltimore Nature reviews. Immunology
  61. Cloned Poliovirus Complementary DNA Is Infectious in Mammalian Cells (1981)
    Vincent R. Racaniello, David Baltimore Science
  62. Activation of Apoptosis Signal-Regulating Kinase 1 (ASK1) by the Adapter Protein Daxx (1998)
    Howard Y. Chang, Hideki Nishitoh et al. Science
  63. Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation (2005)
    Markus W. Covert, Thomas Leung et al. Science
  64. Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance (2010)
    Jesse D. Bloom, David Baltimore et al. Science
  65. Identification of a Protein that Binds to the SH3 Region of Abl and Is Similar to Bcr and GAP-rho (1992)
    Bruce J. Mayer, Gerald Thiel et al. Science
  66. Expression of animal virus genomes (1971)
    David Baltimore Bacteriological Reviews
  67. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. (1988)
    G Q Daley, David Baltimore Proceedings of the National Academy of Sciences
  68. Molecular cloning of poliovirus cDNA and determination of the complete nucleotide sequence of the viral genome. (1981)
    Vincent R. Racaniello, David Baltimore Proceedings of the National Academy of Sciences
  69. Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine (1980)
    Owen N. Witte, Asim Dasgupta et al. Nature
  70. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA (1980)
    Stephen P. Goff, Eli Gilboa et al. Cell
  71. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase (1981)
    Stephen P. Goff, Paula Traktman et al. Journal of Virology
  72. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy (2011)
    Alex Sigal, Jocelyn T. Kim et al. Nature
  73. Antibody-based protection against HIV infection by vectored immunoprophylaxis (2011)
    Alejandro B. Balazs, Joyce Chen et al. Nature
  74. A prudent path forward for genomic engineering and germline gene modification (2015)
    David Baltimore, Paul Berg et al. Science
  75. RNA-Directed DNA Synthesis and RNA Tumor Viruses (1972)
    Howard M. Temin, David Baltimore Advances in virus research
  76. Ribonucleic Acid Synthesis of Vesicular Stomatitis Virus, II. An RNA Polymerase in the Virion (1970)
    David Baltimore, Alice Huang et al. Proceedings of the National Academy of Sciences
  77. Terminal Deoxynucleotidyl Transferase Activity in Human Leukemic Cells and in Normal Human Thymocytes (1975)
    Ronald P. McCaffrey, Robertson Parkman et al. New England Journal of Medicine
  78. Standardized and simplified nomenclature for proteins common to all retroviruses (1988)
    Jonathan Leis, David Baltimore et al. Journal of Virology
  79. Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. (1977)
    James B. Flanegan, Victor Ambros et al. Proceedings of the National Academy of Sciences
  80. Polypeptide cleavages in the formation of poliovirus proteins. (1968)
    Michael F. Jacobson, David Baltimore Proceedings of the National Academy of Sciences
  81. Morphogenesis of poliovirus (1968)
    Michael F. Jacobson, David Baltimore Journal of Molecular Biology
  82. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. (1975)
    Naomi Rosenberg, David Baltimore et al. Proceedings of the National Academy of Sciences
  83. In vitro Synthesis of DNA Complementary to Rabbit Reticulocyte 10S RNA (1972)
    Inder M. Verma, Gary F. Temple et al. Nature New Biology
  84. Primer Requirement and Template Specificity of the DNA Polymerase of RNA Tumor Viruses (1971)
    David Baltimore, Donna Smoler Proceedings of the National Academy of Sciences
  85. Purification and properties of poliovirus double-stranded ribonucleic acid (1966)
    David Baltimore Journal of Molecular Biology

Immediate Impact

124 by Nobel laureates 124 from Science/Nature 168 standout
Sub-graph 1 of 20

Citing Papers

Multiplex Genome Engineering Using CRISPR/Cas Systems
2013 StandoutScience
Nuclear reprogramming to a pluripotent state by three approaches
2010 StandoutNatureNobel
18 intermediate papers

Works of David Baltimore being referenced

Differentiation requires continuous regulation.
1991
Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription.
1991
and 8 more

Author Peers

Author Last Decade Papers Cites
David Baltimore 75494 46402 32214 701 140.0k
Richard A. Flavell 74744 85870 13645 1.2k 176.5k
Tom Maniatis 120104 24042 12262 278 188.4k
Shizuo Akira 78422 162208 28699 1.2k 256.9k
Guido Kroemer 125595 50391 28279 1.3k 229.0k
Michael Karin 112099 59606 56122 646 209.7k
Alberto Mantovani 41830 90088 16219 1.1k 154.3k
Matthias Mann 148683 17834 14084 837 211.4k
Douglas R. Green 79879 34890 14932 605 123.0k
Craig B. Thompson 90608 36314 43942 513 148.6k
John C. Reed 72596 20246 12113 788 106.2k

All Works

Loading papers...

Rankless by CCL
2026